跳至主要内容
临床试验/NCT04783155
NCT04783155招募中不适用

Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes After Lung Transplant: A Randomized Controlled Trial

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年5月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
30
试验地点
1
主要终点
Maximal inspiratory mouth pressure (MIP) measured in cmH2O

研究概览

简要总结

The purpose of this research is to study the effect of training the inspiratory muscles (i.e. the muscle that allow you to breath-in) on exercise capacity, quality of life, and short-term clinical outcomes in patients post lung transplant.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

盲法说明

This is a double-blinded, randomized study

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - All patients who undergo single- or double-lung transplant at Mayo Clinic Florida.

排除标准

  • Patients who do not survive the intra-operative period during the transplant surgery.
  • Patients undergoing retransplantation.
  • Patients undergoing multiorgan transplantation.
  • Patients who are not willing to or who are unable to give written informed consent.

研究组 & 干预措施

12-weeks pulmonary rehabilitation training plus inspiratory muscle training

Experimental

To assess maximum inspiratory pressure, you will be asked to breathe through a device called POWERBreathe Plus®. This device is commercially available and will be provided to you by the study. You will be asked to use this device twice per day, 5 days per week, for 12 weeks. Each session will require you to breathe into the device 30 times. You can use the device at home.

干预措施: POWERBreathe Plus® (Device)

12-weeks pulmonary rehabilitation training plus inspiratory muscle training

Experimental

To assess maximum inspiratory pressure, you will be asked to breathe through a device called POWERBreathe Plus®. This device is commercially available and will be provided to you by the study. You will be asked to use this device twice per day, 5 days per week, for 12 weeks. Each session will require you to breathe into the device 30 times. You can use the device at home.

干预措施: Cardiopulmonary rehabilitation post lung transplant (Other)

12-weeks pulmonary rehabilitation plus placebo (inactive) inspiratory muscle

Placebo Comparator

To assess maximum inspiratory pressure with placebo, you will be asked to breathe through a device called POWERBreathe Plus®. This device is commercially available and will be provided to you by the study. You will be asked to use this device twice per day, 5 days per week, for 12 weeks. Each session will require you to breathe into the device 30 times. You can use the device at home. The resistance will be set to about 5% throughout the study.

干预措施: POWERBreathe Plus® (Device)

12-weeks pulmonary rehabilitation plus placebo (inactive) inspiratory muscle

Placebo Comparator

To assess maximum inspiratory pressure with placebo, you will be asked to breathe through a device called POWERBreathe Plus®. This device is commercially available and will be provided to you by the study. You will be asked to use this device twice per day, 5 days per week, for 12 weeks. Each session will require you to breathe into the device 30 times. You can use the device at home. The resistance will be set to about 5% throughout the study.

干预措施: Cardiopulmonary rehabilitation post lung transplant (Other)

结局指标

主要结局

Maximal inspiratory mouth pressure (MIP) measured in cmH2O

时间窗: 12 weeks

The maximal strength generating capacity of the inspiratory muscles.

次要结局

  • Maximal oxygen uptake (V̇O2max) measured in mL/kg/min(12 weeks)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Bryan Taylor

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验